Pubblicazioni

Risankizumab for the treatment of moderate-to-severe psoriasis. A multicenter, retrospective, 1 year real-life study

2022 - DERMATOLOGIC THERAPY

Caldarola, Giacomo; Zangrilli, Arianna; Bernardini, Nicoletta; Bavetta, Mauro; De Simone, Clara; Graceffa, Dario; Bonifati, Claudio; Faleri, Sara; Giordano, Domenico; Mariani, Marco; Micheli, Adriana; Moretta, Gaia; Pagnanelli, Gianluca; Panasiti, Vincenzo; Provini, Alessia; Richetta, Antonio; Peris, Ketty; Bianchi, Luca

Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: Preliminary results of a prospective pilot study

2017 - CURRENT DRUG TARGETS

Gragnani, Laura; Piluso, Alessia; Urraro, Teresa; Fabbrizzi, Alessio; Fognani, Elisa; Petraccia, Luisa; Genovesi, Alessandro; Giubilei, Lidia; Ranieri, Jessica; Stasi, Cristina; Monti, Monica; Zignego, Anna Linda

Long-term safety and efficacy of imatinib in pulmonary arterial hypertension

2015 - THE JOURNAL OF HEART AND LUNG TRANSPLANTATION

Frost, Adaani E; Barst, Robyn J.; Hoeper, Marius M.; Chang, Hyuk Jae; Frantz, Robert P.; Fukumoto, Yoshihiro; GaliÃ©, Nazzareno; Hassoun, Paul M.; Klose, Hans; Matsubara, Hiromi; Morrell, Nicholas W.; Peacock, Andrew J.; Pfeifer, Michael; Simonneau, GÃ©rald; Tapson, Victor F.; Torres, Fernando; Vizza, Carmine Dario; Lawrence, David; Yang, Wei; Felser, James M.; Quinn, Deborah A.; Ghofrani, Hossein Ardeschir